Cold Chain Technologies (CCT) is strengthening its presence across the Asia Pacific (APAC) region through a series of strategic investments, partnerships, and new facilities designed to enhance support for pharmaceutical, airline, and 3PL customers requiring reliable temperature-controlled logistics.
Building on Regional Momentum
Following the acquisitions of Tower Cold Chain and GCCS, both with established reputations in APAC, CCT is now expanding its networks to ensure faster and more effective access to its passive parcel and pallet shipper solutions.
Ranjeet Banerjee, CEO of Cold Chain Technologies, said:
“With Tower and GCCS providing a strong foundation in APAC, we are building new partnerships and infrastructure so that customers globally can quickly access our solutions. These moves underscore our commitment to supporting life sciences logistics across this critical region.”
Country-Specific Developments
- Japan: A new hub in Tokyo has been launched, alongside a distribution partnership with Hubnet, covering CCT’s Reusable Pallet range.
- China: Shanghai-based TWS, formerly Tower’s distributor, will now manage the full CCT portfolio, expanding customer access across the country.
- Australia & India: Regional operations have been rebranded as CCT Australia and CCT India. In India, growth will be supported by a new manufacturing site in Mumbai, and a strong presence at the Cold Chain Unbroken Conference in Hyderabad, September 2025.
Combining Global Expertise with Local Strength
Amardeep Chahal, Senior VP, Marketing & Corporate Development at CCT, added:
“We’re leveraging the strength of our global portfolio—pallets, parcels, thermal covers, and digital solutions—together with robust local capabilities across APAC. Our investment in the region will continue as we help customers connect their life-changing work to the world through high-quality, dependable cold chain logistics.”
Strengthening Global Cold Chain Connectivity
CCT’s latest APAC initiatives reflect its commitment to innovation, sustainability, and reliability in pharmaceutical logistics, reinforcing its role as a global leader in temperature-sensitive supply chain solutions.